CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 33 enrolled
Drug / intervention
HPV self collectiondevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03551028
NCT03551028N/ACompleted

Cultural Acceptability and Feasibility of HPV Cervical Self Collection Aided by the Mobile

University of Virginia·interventional·Posted Jun 11, 2018·Updated Nov 4, 2024

In Brief

A clinical study evaluating HPV self collection for Cervical Cancer. Completed, enrolled 33 participants across 1 site.

Detailed Summary

Invasive cervical cancer incidence and mortality can be dramatically reduced through early detection and treatment, but many women do not complete screening at recommended intervals. Many low-income women in Virginia remain uninsured and are at significant risk of being medically underserved and failing to complete regular cervical cancer screening. Self-collection of specimens for HPV testing is an innovative approach that may increase access to cervical cancer screening in populations that do not participate in traditional clinic-based screening. Innovative delivery models are needed to reach at-risk populations. This study seeks to explore the acceptability and feasibility of pairing self-collection of HPV samples for DNA testing with mobile mammography in women living in rural Virginia.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCervical Cancer
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedJun 11, 2018
Enrollment StartJul 1, 2016
Primary CompletionMar 31, 2021
TodayJul 2, 2026
Enrollment to primary: 4.8 yearsPosted 8.1 years ago

Interventions

HPV self collectiondevice

The proposed community based participatory study aims to determine whether offering self-collection for HPV testing through the mobile mammography unit is an acceptable and feasible method to increase access to cervical cancer screening for under-screened women in Southwest Virginia.